Total Credits: .75 including .75 AMA PRA Category 1 Credit(s)™, .75 AOA Category 1-A Credit(s)
This program will expire and must be completed by 12/21/25.
*** Please note this program will also be found as part of the 3.25-Credit program Common Diseases & Disorders & Viruses. If you have already completed Common Diseases & Disorders & Viruses, you will not want to choose this program. If you want to learn more about Common Diseases & Disorders & Viruses, choose “Media Types” above and select “Classroom.” ***
This presentation focuses only on the randomized, controlled trial data of diabetes medications that explore the impact on cardiovascular outcomes. The majority of this presentation pertains to the following drug classes: DPP-4 inhibitors, SGLT-2, and GLP-1 medications. The main learning goal is to gain an understanding and awareness of the evidence-based trials that evaluate Type 2 DM medications that meet expectations of cardiovascular risk reduction and how the American Diabetes Association modified the clinical practice guidelines to reflect these important trial findings.
Learning Objectives:
• Understand the historical background and results of CV risk reduction trials with Type 2 Diabetes Meds
• Understand and compare CV outcome trials for more current Type 2 DM pharmacotherapy: DPP-4, GLP-1, and SGLT-2 medications
• Awareness of the 2020 ADA treatment algorithm
Accreditation Statements:
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of .75 AOA Category 1-A Credits and will report CME and specialty credits commensurate with the extent of the physician's participation.
Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this enduring activity for a maximum of .75 AMA PRA Category 1 Creditsä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and Kansas City University College of Osteopathic Medicine. MAOPS is accredited by the ACCME to provide continuing medical education for physicians.
Planning Disclosure:
None of the planners for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Grievance Policy for AOA Credit:
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
| An Overview of Type 2 Diabetes Medications (3.98 MB) | 92 Pages | Available after Purchase |
Dr. Christos Hatzigeorgiou joined the Augusta University faculty as Division Chief of General Internal Medicine after serving in the U.S. Army as a physician leader in clinical, academic, and administrative roles. Dr. Hatzigeorgiou completed his internal medicine residency at Brooke Army Medical Center and a fellowship in General Internal Medicine at Walter Reed Army Medical Center. He completed a Master’s degree in Public Health (Epidemiology and Biostatistics) at Uniform Services University of the Health Science Center. With prior experience of implementing a Patient Center Medical Home, Dr. Hatzigeorgiou is centered on value-based care principles, a proven care model that improves the health of patients through team-based healthcare delivery focused on cost-effective methods. Dr. Hatzigeorgiou has been involved with health service and outcomes research, and evidence-based medicine is a focal point of his training and teaching.
Christos Hatzigeorgiou, DO, discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
Dr. Hatzigeorgiou can be reach at chatzigeorgiou@augusta.edu.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|